Veru Inc VERU

NAS: VERU | ISIN: US92536C1036   30/04/2025
0,542 USD (-1,49%)
(-1,49%)   30/04/2025

24 januari 2023 · VERU ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of February 6, 2023 in the Class Action Filed on Behalf of Veru Inc. Shareholders · Persbericht

24 januari 2023 · VERU INC. (NASDAQ: VERU) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Veru Inc. (NASDAQ: VERU) · Persbericht

23 januari 2023 · VERU INVESTOR NOTICE: ROSEN, A LEADING NATIONAL FIRM, Encourages Veru, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action- VERU · Persbericht

23 januari 2023 · CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Veru Investors of a Lead Plaintiff Deadline of February 6, 2023 · Persbericht

20 januari 2023 · VERU Investors Have Opportunity to Lead Veru Inc. Securities Fraud Lawsuit · Persbericht

21 december 2022 · VERU Investors Have Opportunity to Lead Veru Inc. Securities Fraud Lawsuit · Persbericht

7 december 2022 · INVESTOR NOTICE: Veru Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - VERU · Persbericht

6 december 2022 · Pomerantz Law Firm Investigates Claims On Behalf of Investors of Veru Inc. - VERU · Persbericht

8 maart 2021 · Veru Exploring Strategic Alternatives for its Legacy Female Health Business · Persbericht

2 maart 2021 · Veru to Participate in Fireside Chat at the H.C. Wainwright Global Life Sciences Conference · Persbericht

23 februari 2021 · Veru Submits New Drug Application for Proprietary TADFIN for BPH · Persbericht

18 februari 2021 · Veru Announces Pricing of Public Offering of Common Stock · Persbericht

17 februari 2021 · Veru Announces Proposed Public Offering of Common Stock · Persbericht

10 februari 2021 · Veru Sets Another Quarterly Record in Both Net Revenues and in Gross Profit for Fiscal 2021 First Quarter · Persbericht

8 februari 2021 · Veru Reports Positive Phase 2 Clinical Results of VERU-111 in Hospitalized COVID-19 Patients at High Risk for Acute Respiratory Distress Syndrome · Persbericht

27 januari 2021 · Veru to Report Fiscal 2021 First-Quarter Financial Results, Host Conference Call on February 10th · Persbericht

Mijn selecties